Company Overview and News
The buying fell while the selling among directors was flat based on exchange filings from April 16 to 20. Buyers outweighed sellers with 48 companies that recorded 247 purchases worth HK$1.13 billion (US$144.1 million) versus 16 companies with 73 disposals worth HK$79 million.
Executive Council convener Bernard Charnwut Chan urged all Mandatory Provident Fund operators to improve their governance standards, warning that his own experience showed it was better to go the extra mile than draw the scrutiny of regulators.
Asia Financial Holdings, which owns one of the largest general insurers in Hong Kong and is headed by the city’s executive council convenor Bernard Chan, reported a 105.5 per cent profit increase in the first half of the year.
The deal marks the second purchase of a Hong Kong-based insurer by a mainland firm in the past two weeks
Asia Financial Holdings, the city-based investment holding company that focuses on financial businesses, is planning to use the HK$1 billion (US$130 million) it earns from the disposal of its holdings in Hong Kong Life for a special dividend or other acquisition opportunities, according to a top official.
The HK$7.1 billion takeover of Hong Kong Life boost share price of Asia Financial, Chong Hing Bank
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Hong Kong Life Insurance, an insurer owned by five Hong Kong financial institutions, was sold to First Origin International for HK$7.1 billion.
Hong Kong Life, a joint venture life insurance company owned by five financial firms, is drawing particular takeover interest thanks to its business portfolio and bank branch network. Its corporate history can also illustrate how a group of smaller lenders can join hands to compete with bigger players.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...